Cellular findings show Telomir-Zn modulates intracellular metal balance linked to oxidative stress, mitochondrial dysfunction ...

Cellular findings show Telomir-Zn modulates intracellular metal balance linked to oxidative stress, mitochondrial dysfunction, DNA methylation instability, and genomic integrity-without relying on cyt ...

Research from NeuroQure, a biotechnology company specializing in autism spectrum disorder, has led to the development of a ...

N2OFF, Inc. (NASDAQ: NITO) (“N2OFF” and the “Company”), a drug discovery company that is also investing in solar energy ...

People are suddenly very concerned about the powerhouse of the cell.

For decades, scientists have known that a misbehaving protein sits at the heart of Parkinson’s disease, yet the precise chain ...

Reports New Cellular Data Demonstrating Coordinated Intracellular Zinc Increase And Iron Reduction With Telomir-Zn. Telomir Pharmaceuticals (NASDAQ: TELO) announced new cellular study results showing ...

Plant‐pathogenic fungi rely on finely tuned cellular processes to invade host tissues and sustain infection. This study ...

Down in the dumps? Help might be hiding in your fridge. A new, first-of-its-kind study suggests a controversial diet could ease severe, drug-resistant depression — with improvements showing up in as ...

Fruits such as berries, apples, citrus, pomegranates, kiwis, and avocados are especially beneficial for healthy aging and ...

Pharming Group has transitioned from a speculative play to a fundamentally attractive, cash-generating rare disease company.

The EMA’s positive opinion on Kygevvi marks a turning point for patients with TK2d, an ultra-rare genetic muscle disease previously managed only with supportive care.